SPIA
FTXH icon

Steward Partners Investment Advisory’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Steward Partners Investment Advisory’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.9K Sell
1,046
-29
-3% -$991 ﹤0.01% 2946
2025
Q4 		$35.4K Sell
1,075
-1
-0.1% -$31 ﹤0.01% 2855
2025
Q3 		$30.7K Sell
1,076
-1,650
-61% -$44.9K ﹤0.01% 2877
2025
Q2 		$69.9K Sell
2,726
-684
-20% -$17.3K ﹤0.01% 2297
2025
Q1 		$93.7K Sell
3,410
-4,847
-59% -$134K ﹤0.01% 2050
2024
Q4 		$223K Sell
8,257
-9
-0.1% -$253 ﹤0.01% 1547
2024
Q3 		$238K Sell
8,266
-9,496
-53% -$272K ﹤0.01% 1439
2024
Q2 		$484K Sell
17,762
-46,094
-72% -$1.23M 0.01% 1078
2024
Q1 		$1.79M Buy
63,856
+8,887
+16% +$245K 0.02% 612
2023
Q4 		$1.46M Sell
54,969
-1,703
-3% -$42.9K 0.02% 601
2023
Q3 		$1.45M Buy
56,672
+41,569
+275% +$1.1M 0.02% 550
2023
Q2 		$395K Sell
15,103
-67,540
-82% -$1.78M 0.01% 1018
2023
Q1 		$2.16M Buy
82,643
+14,744
+22% +$395K 0.03% 450
2022
Q4 		$1.86M Buy
67,899
+35,814
+112% +$953K 0.03% 470
2022
Q3 		$771K Buy
32,085
+31,670
+7,631% +$819K 0.01% 716
2022
Q2 		$11K Hold
415
– – ﹤0.01% 2483
2022
Q1 		$11K Hold
415
– – ﹤0.01% 2613
2021
Q4 		$11K Hold
415
– – ﹤0.01% 2557
2021
Q3 		$11K Hold
415
– – ﹤0.01% 2567
2021
Q2 		$11K Hold
415
– – ﹤0.01% 5857
2021
Q1 		$10.6K Hold
415
– – ﹤0.01% 2756
2020
Q4 		$11K Hold
415
– – ﹤0.01% 2271
2020
Q3 		$10K Buy
+415
New +$9.96K ﹤0.01% 2134

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.28B AUM 27.63% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Steward Partners Investment Advisory's FTXH Position: Q1 2026 in Review

Steward Partners Investment Advisory reduced its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 2.7% in Q1 2026, selling an estimated $991 and leaving 1,046 shares worth $35.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2946.

Steward Partners Investment Advisory first reported a position in FTXH in Q3 2020 and has held it in 23 quarters since. The position peaked at $2.16M in Q1 2023. 32 funds tracked by Wall St. Rank hold FTXH as of Q1 2026.

  • Steward Partners Investment Advisory held 1,046 shares of First Trust Nasdaq Pharmaceuticals ETF worth $35.9K as of Q1 2026.
  • Steward Partners Investment Advisory sold 29 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2026, an estimated $991.
  • First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #2946 holding.
  • Steward Partners Investment Advisory first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q3 2020 and has held it in 23 quarters since.
  • Steward Partners Investment Advisory's First Trust Nasdaq Pharmaceuticals ETF position peaked at $2.16M in Q1 2023.
  • 32 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.